Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer

Psycho-Oncology

Volumn 22, Issue 6, 2013, Pages 1328-1335

  Tavlarides, Andrea M ^a   Ames, Steven C ^a   Diehl, Nancy N ^a   Joseph, Richard W ^a   Castle, Erik P ^b   Thiel, David D ^a   Broderick, Gregory A ^a   Parker, Alexander S ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

anxiety; oncology; prostate cancer; quality of life; surgery

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANXIETY; ARTICLE; CANCER AGGRESSIVENESS; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; DEPRESSION; DISEASE ACTIVITY; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY; PSYCHOLOGICAL RATING SCALE; RACE DIFFERENCE; SEXUAL FUNCTION; SEXUAL SATISFACTION;

AGE FACTORS; AGED; ANXIETY; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL;

EID: 84878799620     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3138     Document Type: Article

References (27)

1. American Cancer Society. Cancer Facts and Figures 2010. American Cancer Society: Atlanta, GA, 2010.
2. Zincke H, Osterling JE, Blute ML, et al,. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850-1857.
3. Consedine NS, Adjei BA, Ramirez PM, et al,. An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency. Cancer Epidemiol Biomarkers Prev 2008; 17 (7): 1631-1639.
4. Nelson GJ, Weinberger MI, Balk E, et al,. The chronology of distress, anxiety, and depression in older prostate cancer patients. Oncologist 2009; 14 (9): 891-899.
5. Khan NF, Ward AM, Watson E, et al,. Consulting and prescribing behaviour for anxiety and depression in long-term survivors of cancer in the UK. Eur J Cancer 2010; 46 (18): 3339-3344.
6. Johansson E, Bill-Axelson A, Holmberg L, Onelov E, et al,. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: The randomized Scandinavian Prostate Cancer Group Study Number 4 (SPGG-4) clinical trial. Eur Urol 2009; 55 (2): 422 -0.
7. Nelson CJ, Mulhall JP, Roth AJ,. The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer. J Sex Med 2011; 8 (2): 560-566.
8. Kahana B, Kahana E, Deimling G, et al,. Determinants of altered life perspectives among older-adult long-term cancer survivors. Cancer Nurs 2011; 34 (3): 209-218.
9. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al,. Quality of life and non-pain symptoms in patients with cancer. J Pain Symptom Manage 2009; 38 (2): 216-233.
10. Messaoudi R, Menard J, Ripert T, et al,. Erectile dysfunction and sexual health after radical prostatectomy: impact of sexual motivation. Int J Impot Res 2011; 23 (2): 81-86.
11. Roth AJ, Rosenfeld B, Kornlith AB, et al,. The Memorial Anxiety Scale for Prostate Cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 2003; 97: 2910-2918.
12. Roth A, Nelson CJ, Rosenfeld, B, et al,. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 2006; 47 (4): 340-347.
13. Korfage IJ, Essink-Bot ML, Janssens AC, et al,. Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 2006; 94 (8): 1093-1098.
14. Gore JL, Gollapudi, K, Bergman J, et al,. Correlates of bother following treatment for clinically localized prostate cancer. J Urol 2010; 184 (4): 1309-1315.
15. Gerbershagen HJ, Ozgur E, Straub K, et al,. Prevalence, severity, and chronicity of pain and general health- related quality of life in patients with localized prostate cancer. Eur J Pain 2008; 12 (3): 339-350.
16. Choo R, Klotz L, Danjoux C, et al,. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002; 167: 1664-1669.
17. Wei JT, Dunn RL, Litwin MS, et al,. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. J Urol 2000; 56: 899-905.
18. Rosen RC, Riley A, Wagner G, et al,. The international index of erectile function (IIEF): a multidimensional scale for assessment if erectile dysfunction. J Urol 1997; 49 (6): 822-830.
19. SAS Institute Inc. SAS® 9.2 Companion for Windows (2nd edn). SAS Institute Inc: Cary, NC, 2010.
20. Pietrow PK, Parekh DJ, Smith JA Jr., et al,. Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. J Urol 2001; 166 (6): 2286-2290.
21. Clark JA, Bokhour BG, Inui TS, et al,. Measuring patients' perceptions of the outcome of treatment for early prostate cancer. Med Care 2003; 41 (8): 923-936.
22. van den Bergh, RCN, Essink-Bot, ML, Roobol MJ,. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol 2010; 183 (5): 1786-1791.
23. Dale W, Hemmerich J, Meltzer D,. Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially mixed population. Psycho-Oncology 2007; 16 (5): 493-498.
24. van de Bergh RC, Korfage IJ, Borsboom GJ, et al,. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the Memorial Anxiety Scale for Prostate Cancer. Qual Life Res 2009; 18 (8): 1061-1066.
25. Dale W, Hemmerich J, Bylow K, et al,. Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical recurrence in older men: a prospective cohort study. J Clin Oncol 2009; 27 (10): 1557-1563.
26. Spiegel D, Bloom JR, Kraemer HC, Gottheil E,. Effect of psychological treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2 (8668): 888-891.
27. Davison BJ, Breckon E,. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns 2012; 87 (3): 369-74.